ESC 2021: Patients with Prior Myocardial Infarction and Gum Disease Face Higher Risk of Heart Disease
Periodontitis was associated with an increased risk for CVD, particularly among patients with past myocardial infarction, in a new study being presented at ESC Congress 2021.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of August 25, 2021
The Delta variant makes up approximately 98% of COVID-19 cases in the US, according to the latest CDC estimates.
ESC 2021: Despite Smoking Less, Women Find it Harder to Quit Than Men
New findings being presented at ESC Congress 2021 highlight the need for smoking cessation services tailored to the specific needs of women.
Adult Vaccination Against Preventable Diseases Now Urgent, says NAIIS
Low rates of routine adult vaccination, reduced further during the 2020-21 pandemic months, threaten a surge in these conditions as the US reopens, says the National Adult and Influenza Immunization Summit.
Rivaroxaban: New Indication for Use in PAD Following Lower Extremity Revascularization
With the post-LER PAD indication, rivaroxaban becomes the only anticoagulant in 2 decades to demonstrate safety and efficacy in the high-risk population.
How Effective is the Flu Vaccine: 10 Questions on Patient Misconceptions
Influenza season brings vaccine fear and misconceptions every year. Stay ahead of patients with our quiz on their questions for you.
ESC 2021: The Risk of Young-onset Heart Attack May Go Beyond Family History
Younger adults with myocardial infarction are more likely to be smokers, obese, and have hypertension than their peers, suggests a new study being presented at the ESC Congress 2021.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of August 24, 2021
Data from the CDC on the Delta variant and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Medical Economics Offers Free Bootcamp
Two-day business training filled with tips for physicians.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of August 23, 2021
Atogepant for Migraine Prevention Meets Primary, Secondary Endpoints
Oral CGRP inhibitor atogepant significantly reduced monthly headache days and improved daily function in adults with 4 to 14 headaches per month.
FDA Fully Approves Pfizer-BioNTech COVID-19 Vaccine
The Pfizer-BioNTech COVID-19 vaccine is the first to receive full approval from the FDA.
8 More Ways to Talk to the Vaccine-hesitant
Talking to the COVID-19 vaccine-hesitant folks in your circle can be difficult. These 8 slides offer some new and some tried and true tips on how to approach the topic
FDA Grants Insulin Lispro-aabc Label Expansion for use in Insulin Pumps
The novel prandial insulin formulation from Eli Lilly is now approved for administration via continuous subcutaneous insulin infusion with an insulin pump.
AAFP to FDA: Authorize COVID-19 Vaccination for US Children
AAFP, citing the increased health threat posed by the SARS-CoV-2 Delta variant, is calling on the FDA to expand current EUA to include patients younger than 12 years.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of August 20, 2021
NIH: Convalescent Plasma Did Not Prevent Disease Progression in COVID-19 Outpatients
According to a new NIH-funded study, early administration of COVID-19 convalescent plasma in high-risk outpatients did not prevent disease progression.
COVID-19: Even Short Hospitalizations Lead to Long COVID Symptoms, Financial Hardship
COVID-19 patients after just 5 days or less in the hospital report new or worsened symptoms, impaired daily function, and significant financial loss.
COVID-19 Vaccine Performance: What’s Currently Known?
How effective are the 3 authorized COVID-19 vaccines against SARS-CoV-2 infection? Virus variants? Get updated on the latest evidence in our quick slideshow.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of August 19, 2021